Attorneys for an Alabama man who alleges he sustained various injuries after taking the drug Reglan have filed a lawsuit against the makers of the drug, which is the subject of widespread litigation nationwide.
Philadelphia lawyers L. Leonard Lundy and Jordan Schlossberg, of the Lundy Law firm, filed the civil action May 25 in the Philadelphia Court of Common Pleas.
According to the complaint, Mosely ingested Metoclopramide, which is the generic equivalent of Reglan, for a three-year period, from May 2006 to May 2009.
The lawsuit states that after taking the drug, which is designed to treat certain reflux-related ailments, for an extended period of time, Mosely was diagnosed with Tardive Dyskinesia, which is a potentially permanent disease that causes involuntary physical movements.
The lawsuit states that Mosely also experienced financial loss and emotional injuries due to his affliction.
The lawsuit lists as brand name defendants Wyeth LLC, Wyeth Pharmaceuticals, Inc., Pfizer Inc., and Schwarz Pharma, Inc.
It lists as generic defendants Teva Pharmaceuticals USA and Pliva, Inc.
The complaint accuses the defendants of strict liability in both design defect and failure to warn, negligence, fraud and intentional misrepresentation, constructive fraud, breach of implied warranty, unfair and deceptive trade practices, unjust enrichment, negligent misrepresentation, civil conspiracy, gross negligence/malice, and loss of consortium.
The plaintiff seeks unspecified compensatory and punitive damages, along with attorneys’ fees and other court-related costs.
The plaintiff has demanded a jury trial. The case currently awaits management.
The case number is 110502976.
Reglan mass tort claim filed
ORGANIZATIONS IN THIS STORY